Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
At NINGBO INNO PHARMCHEM CO.,LTD., we are committed to shedding light on the science behind critical pharmaceutical ingredients. Today, we explore Tasimelteon, a compound that exemplifies precision in pharmaceutical therapy by targeting specific biological pathways to improve sleep regulation.
Tasimelteon functions as a selective dual melatonin receptor agonist. Melatonin, a hormone produced by the pineal gland, is central to regulating the body's 24-hour internal clock, or circadian rhythm. It signals to the brain that it is time to sleep. Tasimelteon mimics and enhances this natural signaling process by binding to and activating two key melatonin receptors: MT1 and MT2. These receptors are predominantly found in the suprachiasmatic nucleus (SCN), the master circadian clock in the brain. By stimulating MT1 and MT2 receptors, Tasimelteon helps to reset and maintain a healthy circadian rhythm.
This precise action is critical for treating conditions such as Non-24-Hour Sleep-Wake Disorder (Non-24HSWD). This disorder often affects blind individuals who lack sufficient light exposure to synchronize their internal clock. Without this external cue, their circadian rhythm can become desynchronized, leading to irregular sleep patterns, including difficulty falling asleep at night and excessive daytime sleepiness. Tasimelteon provides a pharmacological solution to re-entrain the internal clock, helping to establish a more regular sleep-wake cycle. The efficacy of tasimelteon for Non-24HSWD is well-documented.
Moreover, Tasimelteon is utilized to manage nighttime sleep disturbances in patients with Smith-Magenis Syndrome (SMS). This genetic disorder is frequently accompanied by significant disruptions in sleep patterns, such as difficulty initiating sleep and frequent nighttime awakenings. Tasimelteon's ability to modulate melatonin receptor activity offers a therapeutic avenue to improve sleep quality and regularity in individuals with SMS. Research on melatonin receptor agonists like Tasimelteon continues to expand our understanding of sleep chronobiology.
The development of Tasimelteon represents a significant advancement in pharmaceutical science, offering a targeted approach to complex sleep disorders. As a supplier of high-quality pharmaceutical intermediates and active ingredients, NINGBO INNO PHARMCHEM CO.,LTD. plays a vital role in making such innovative treatments accessible. Our focus on providing reliable tasimelteon API ensures that researchers and manufacturers have the materials needed to advance sleep disorder therapies. The detailed information on tasimelteon CAS 609799-22-6 is crucial for accurate sourcing and application.
In summary, Tasimelteon's sophisticated mechanism of action, targeting melatonin receptors to regulate circadian rhythms, makes it an indispensable pharmaceutical for addressing challenging sleep disorders. NINGBO INNO PHARMCHEM CO.,LTD. is proud to support the medical community by providing this essential compound.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
